In this panel discussion video, the Melanoma Research Foundation (MRF) spoke with Dr. Howard Kaufman, MD (Director, Rush University Cancer Center), Dr. Michael Atkins, MD (Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center) and Dr. John Kirkwood, MD (Director of the Melanoma and Skin Cancer Program at the University of Pittsburgh) about guidelines released by the Society for Immunotherapy of Cancer (SITC) for the immunotherapy treatment of melanoma patients. The experts explain how these guidelines outline protocols and tips to oncologists and melanoma patients considering immunotherapy and also which treatments are available.
Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.
SITC Cancer Immunotherapy Guidelines https://www.sitcancer.org/research/cancer-immunotherapy-guidelines
Journal for ImmunoTherapy of Cancer https://jitc.biomedcentral.com/articles
Patient Resource Guides https://www.sitcancer.org/connectedold/patient
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com